Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.155
-0.025 (-2.12%)
Nov 18, 2026, 1:21 PM EST - Market open
Gain Therapeutics Stock Forecast
GANX's stock price has decreased by -58.16% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 5 analysts polled by S&P Global, Gain Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $6.60. The average 1-year stock price forecast is 471.43% higher than the current stock price, while the lowest is $5.00 (+332.90%) and the highest is $8.00 (+592.64%).
Price Target: $6.60 (+471.43%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Gain Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +332.90% | Nov 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +592.64% | Nov 12, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $7 | Buy | Maintains | $7 | +506.06% | Nov 11, 2026 |
| BTIG | BTIG | Buy Maintains $5 | Buy | Maintains | $5 | +332.90% | Nov 11, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $8 | Buy | Maintains | $8 | +592.64% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.40
from -0.61
EPS Next Year
-0.63
from -0.40
EPS and Forward PE are based on non-GAAP adjusted numbers.